Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure

References

• American Heart AssociationHeart disease and stroke statistics–2006 update2006 Accessed January 2, 2005. URL: http://www.americanheart.org/downloadable/heart/1136308648540Statupdate2006.pdf
   Google Scholar
• BristowMRMechanistic and clinical rationales for using beta-blockers in heart failureJ Card Fail200062 Suppl 18110908093
   PubMed Web of Science ®Google Scholar
• CarsonPZiescheSJohnsonGRacial differences in response to therapy for heart failure: Analysis of the Vasodilator-Heart Failure TrialsJ Card Fail1999517818710496190
   PubMedGoogle Scholar
• CardilloCKilcoyneCMCannonRORacial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulationHypertension199831123512399622135
   PubMed Web of Science ®Google Scholar
• CohnJNArchibaldMPZiescheSEffect of vasodilator therapy on mortality in chronic congestive heart failureN Engl J Med19863141547523520315
   PubMed Web of Science ®Google Scholar
• CohnJNJohnsonGZiescheSA comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failureN Engl J Med1991325303102057035
   PubMed Web of Science ®Google Scholar
• DaiberAMulschAUlrichHThe oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazineAm J Cardiol20059625i36i15979427
   PubMed Web of Science ®Google Scholar
• DriesDLExnerDVGershBJRacial differences in the outcome of left ventricular dysfunctionN Engl J Med19993406091610029645
   PubMed Web of Science ®Google Scholar
• ElkayamUBitarFEffects of nitrates and hydralazine in heart failure: Clinical evidence before the African American heart failure trialAm J Cardiol200596Suppl37i43i
   PubMedGoogle Scholar
• ExnerDVDriesDLDomanskiMJLesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunctionN Engl J Med20013441351711333991
   PubMed Web of Science ®Google Scholar
• GogiaHMehraAParikhSPrevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failureJ Am Coll Cardiol1995261575807594088
   PubMed Web of Science ®Google Scholar
• HareJMNitroso-redox balance in the cardiovascular systemN Engl J Med20043512112211415533853
   PubMed Web of Science ®Google Scholar
• HeinLAltmanJDKobilkaBKTwo functionally distinct a2adrenergic receptors regulate sympathetic neurotransmissionNature199940218118410647009
   PubMed Web of Science ®Google Scholar
• HuntSAAbrahamWTChinMHACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm SocietyCirculation2005112e15423516160202
   PubMed Web of Science ®Google Scholar
• JanssensSPokreiszPSchoonjansLCardiomyocytespecific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarctionCirc Res20049412566215044322
   PubMed Web of Science ®Google Scholar
• KahnDFDuffySJEffects of black race on forearm resistance vessel functionHypertension20024019520112154113
   PubMed Web of Science ®Google Scholar
• KalinowskiLDobruckiITTomasianDRace-specific differences in endothelial function: Predisposition of African Americans to vascular diseaseCirculation200410925111715159296
   PubMed Web of Science ®Google Scholar
• KonstamMARousseauMFKronenbergMWEffects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD InvestigatorsCirculation19928643181638712
   PubMed Web of Science ®Google Scholar
• MalinskiTUnderstanding nitric oxide physiology in the heart: A nanomedical approachAm J Cardiol200596Suppl13i24i15979424
   PubMedGoogle Scholar
• McNamaraDMHolubkovRPostavaLEffect of Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failureCirculation2003107159860212668492
   PubMed Web of Science ®Google Scholar
• McNamaraDMTamSWSabolinskiMLThe genetic risk sub-study of the African American heart failure trial (A-HeFT): Impact of genetic variation of NOS32005Abstract presented at the 2005 Heart Failure Society of America national conference Retrieved June 22, 2006 from http://www.abstracts2view.com/hfsa05/view.php?nu=HFSA5L1_232
   Google Scholar
• MERIT-HF Study GroupEffect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)Lancet19993532001710376614
   PubMed Web of Science ®Google Scholar
• PackerMBristowMRCohnJNThe effect of carvedilol on morbidity and mortality in patients with chronic heart failureN Engl J Med19963341349558614419
   PubMed Web of Science ®Google Scholar
• PierpontGLCohnJNFranciosaJACombined oral hydralazine-nitrate therapy in left ventricular failure: hemodynamic equivalency to sodium nitroprussideChest73813620563
   PubMed Web of Science ®Google Scholar
• PrabhuSDNitric oxide protects against pathological ventricular remodeling: Reconsideration of the role of NO in the failing heartCirc Res20049411557
   Web of Science ®Google Scholar
• SmallKMWagonerLELevinAMSynergistic polymorphisms of b1- and a2c-adrenergic receptors and the risk of congestive heart failureN Engl J Med200234711354212374873
   PubMed Web of Science ®Google Scholar
• TaylorALThe African American heart failure trial (A-HeFT): rationale and methodologyJ Card Fail20039SupplS2161914583892
   PubMedGoogle Scholar
• TaylorALZiescheSCombination of isosorbide dinitrate and hydralazine in blacks with heart FailureN Engl J Med200435120495715533851
   PubMed Web of Science ®Google Scholar
• TaylorALThe African American heart failure trial: A clinical trial updateAm J Cardiol200596Suppl44i8i16226935
   PubMedGoogle Scholar
• TesauroMThompsonWCRoglianiIntracellular processing of the endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs glutamate at position 298Proc Natl Acad Sci U S A2000972832510717002
   PubMed Web of Science ®Google Scholar
• The Beta-Blocker Evaluation of Survival Trial InvestigatorsA trial of the beta-blocker bucindolol in patients with advanced chronic heart failureN Engl J Med20013441659166711386264
   PubMed Web of Science ®Google Scholar
• The CONSENSUS Trial Study GroupEffects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)N Engl J Med19873161429352883575
   PubMed Web of Science ®Google Scholar
• The SOLVD InvestigatorsEffect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failureN Engl J Med1991324293302
   Google Scholar
• UngerPBerkenboomGFontaineJInteraction between hydralazine and nitrovasodilators in vascular smooth muscleJ Cardiovasc Pharmacol1993214784837681511
   PubMed Web of Science ®Google Scholar
• WagonerLEStarlingRCO’ConnorCMCardiac function and heart failureJ Am Coll Cardiol2006471822
   Google Scholar
• WollertKCDrexlerHRegulation of cardiac remodeling by nitric oxide: Focus on cardiac myocyte hypertrophy and apoptosisHeart Failure Reviews200273172512379817
   PubMedGoogle Scholar
• YancyCWHeart failure in african americansAm J Cardiol200596Suppl3i12i
   PubMedGoogle Scholar